Vera Therapeutics, Inc.

NASDAQ:VERA

Biotechnology

Healthcare
$26.75 +0.27%

+$0.09 today

Market cap
$1.93B
Beta
0.95
P/E (TTM)
-6.8
EPS (TTM)
-$5.16
52W Low $19.07High $56.05

Volume 1.05M

Average 1.18M

Balance Sheet

Inspect the capital base behind the business.

Assets

$734.73M

FY 2025 · Annual

+12.1% YoY

Liabilities

$130.21M

FY 2025 · Annual

+65.8% YoY

Equity

$604.52M

FY 2025 · Annual

+4.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents79.67M43.46M45.68M92.65M354.73M
Short-term Investments071.19M115.04M548.21M359.86M
Net Receivables0003.77M3.29M
Inventory00000
Other Current Assets480K719K3.22M913K2.54M
Total Current Assets82.54M125.7M172.02M651.22M728.88M
Property, Plant & Equipment (Net)05.22M3.04M4.33M1.92M
Goodwill00000
Intangible Assets00000
Long-term Investments867K58K11K00
Tax Assets00000
Other Non-current Assets344K455K471K131K3.93M
Total Non-current Assets1.21M5.74M3.52M4.46M5.85M
Total Assets83.75M131.44M175.55M655.68M734.73M
Account Payables1.39M11.99M11.12M7.67M21.9M
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities377K04.82M01.37M
Total Current Liabilities7.69M25.6M22.3M25.37M53.46M
Long-term Debt4.92M24.81M49.88M50.69M74.84M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities1.54M286K286K00
Total Non-current Liabilities6.47M28.93M51.56M53.16M76.76M
Total Liabilities14.16M54.53M73.86M78.53M130.21M
Common Stock21K28K44K64K71K
Retained Earnings(124.06M)(213.11M)(309.1M)(461.25M)(760.87M)
Accumulated OCI(0)(224K)251K393K786K
Other Stockholders Equity00000
Minority Interest00000
Total Equity69.59M76.91M101.69M577.16M604.52M
Total Debt4.92M31.29M53.71M54.64M77.31M
Net Debt(74.75M)(12.17M)8.03M(38.01M)(277.42M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$48.9M
Short-term Investments$450.3M
Other Current$28.3M
Total Current Assets$527.5M
PP&E (Net)$1.7M
Other Non-current$3.8M
Total Non-current Assets$5.5M
Total Assets$533.0M

Analysis

Selected assets total $533.0M for Latest. The largest visible component is Short-term Investments at $450.3M, about 84.5% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingNov 10, 2026
10-QQuarterly reportNov 5, 2026
8-KCurrent reportNov 5, 2026
4Statement of changes in beneficial ownershipSep 17, 2026
8-KCurrent reportSep 15, 2026

How much cash does VERA have?

Vera Therapeutics, Inc. (VERA) reported $354.73M in cash and equivalents in fiscal 2025.

How much debt does VERA carry?

Vera Therapeutics, Inc. (VERA) reported $77.31M of total debt, with net debt of -$277.42M.